Company / Tangible Book Value per Share
NovoCure Ltd Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.14
FY2025
5-year range
$3.14 / $4.24
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
#103 of 163
Health Care
What the data says
At $3.14, NovoCure Ltd's tangible book value per share ranks #103 of 163 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $4.24 in FY2022 to $3.14 in FY2025.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of -8.1%.
Declined from $3.45 to $3.14 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -9.6%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
#103 of 163 in Health CareTop 63% of 163This company $3.14 Sector average $18.28
▼
-82.8% below sector average
Key checks
Key Insights
- NovoCure Ltd's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 6.7% year-over-year.
- Ranks #103 out of 163 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | -6.7% |
| FY2024 | $3.36 | -2.5% |
| FY2023 | $3.45 | -18.7% |
| FY2022 | $4.24 | +5.8% |
| FY2021 | $4.01 | -16.2% |
| FY2020 | $4.79 | +105.0% |
| FY2019 | $2.34 | +86.2% |
| FY2018 | $1.25 | -3.8% |
| FY2017 | $1.30 | -23.2% |
| FY2016 | $1.70 | -90.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026